Literature DB >> 15657225

Expression of connexins 40 and 43 in human left atrium in atrial fibrillation of different aetiologies.

U Wetzel1, A Boldt, J Lauschke, J Weigl, P Schirdewahn, A Dorszewski, N Doll, G Hindricks, S Dhein, H Kottkamp.   

Abstract

OBJECTIVE: To test the hypothesis that atrial fibrillation (AF) is associated with changes in the expression of connexins 40 and 43 in the left atrium with more pronounced changes in mitral valve disease than in lone AF.
METHODS: Protein concentrations of connexin 40 and connexin 43 were analysed in left atrial tissue of patients undergoing cardiac surgery. One group of patients had lone AF (n = 41), one group had AF and mitral valve repair (n = 36), and one group in sinus rhythm served as controls (n = 15).
RESULTS: Western blot analysis of connexin 40 and connexin 43 expression showed an increase of both gap junctional proteins (connexin 43 > connexin 40) in patients with AF of all forms compared with patients in sinus rhythm (p = 0.01 and p = 0.011, respectively). Subgroup analysis showed increased concentrations of connexin 40 in lone AF and AF with mitral valve disease compared with sinus rhythm (p = 0.06 and p = 0.029, respectively), whereas the same analysis for connexin 43 reached significance only in the mitral valve disease group (p = 0.031). No differences in connexin 40 and connexin 43 expression were detectable between lone AF and AF with mitral valve disease. Within the groups connexin 40 and connexin 43 expression did not differ between patients with paroxysmal AF and patients with chronic AF.
CONCLUSION: The present study shows for the first time that AF can induce changes in the left atrium with increased connexin expression. Furthermore, no systematic differences between patients with paroxysmal and chronic AF were detected.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15657225      PMCID: PMC1768705          DOI: 10.1136/hrt.2003.024216

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  36 in total

Review 1.  Gap junctions in cardiovascular disease.

Authors:  H J Jongsma; R Wilders
Journal:  Circ Res       Date:  2000-06-23       Impact factor: 17.367

Review 2.  Immunocytochemical analysis of connexin expression in the healthy and diseased cardiovascular system.

Authors:  N J Severs; S Rothery; E Dupont; S R Coppen; H I Yeh; Y S Ko; T Matsushita; R Kaba; D Halliday
Journal:  Microsc Res Tech       Date:  2001-02-01       Impact factor: 2.769

Review 3.  Cardiac gap junction channels: modulation of expression and channel properties.

Authors:  A A van Veen; H V van Rijen; T Opthof
Journal:  Cardiovasc Res       Date:  2001-08-01       Impact factor: 10.787

Review 4.  Connexins and impulse propagation in the mouse heart.

Authors:  J Jalife; G E Morley; D Vaidya
Journal:  J Cardiovasc Electrophysiol       Date:  1999-12

5.  Altered connexin expression in human congestive heart failure.

Authors:  E Dupont; T Matsushita; R A Kaba; C Vozzi; S R Coppen; N Khan; R Kaprielian; M H Yacoub; N J Severs
Journal:  J Mol Cell Cardiol       Date:  2001-02       Impact factor: 5.000

6.  Effects of chronic atrial fibrillation on gap junction distribution in human and rat atria.

Authors:  L Polontchouk; J A Haefliger; B Ebelt; T Schaefer; D Stuhlmann; U Mehlhorn; F Kuhn-Regnier; E R De Vivie; S Dhein
Journal:  J Am Coll Cardiol       Date:  2001-09       Impact factor: 24.094

7.  Gap junctional remodeling in relation to stabilization of atrial fibrillation in the goat.

Authors:  H M van der Velden; J Ausma; M B Rook; A J Hellemons; T A van Veen; M A Allessie; H J Jongsma
Journal:  Cardiovasc Res       Date:  2000-06       Impact factor: 10.787

8.  The gap-junctional protein connexin40 is elevated in patients susceptible to postoperative atrial fibrillation.

Authors:  E Dupont; Y Ko; S Rothery; S R Coppen; M Baghai; M Haw; N J Severs
Journal:  Circulation       Date:  2001-02-13       Impact factor: 29.690

9.  Cardiac conduction abnormalities in mice lacking the gap junction protein connexin40.

Authors:  S Verheule; C A van Batenburg; F E Coenjaerts; S Kirchhoff; K Willecke; H J Jongsma
Journal:  J Cardiovasc Electrophysiol       Date:  1999-10

10.  Gap junction remodeling in hypertrophied left ventricles of aortic-banded rats: prevention by angiotensin II type 1 receptor blockade.

Authors:  L Emdad; M Uzzaman; Y Takagishi; H Honjo; T Uchida; N J Severs; I Kodama; Y Murata
Journal:  J Mol Cell Cardiol       Date:  2001-02       Impact factor: 5.000

View more
  20 in total

Review 1.  Increasing gap junctional coupling: a tool for dissecting the role of gap junctions.

Authors:  Lene Nygaard Axelsen; Ketil Haugan; Martin Stahlhut; Anne-Louise Kjølbye; James K Hennan; Niels-Henrik Holstein-Rathlou; Jørgen Søberg Petersen; Morten Schak Nielsen
Journal:  J Membr Biol       Date:  2007-06-14       Impact factor: 1.843

Review 2.  The Stress-Response MAP Kinase Signaling in Cardiac Arrhythmias.

Authors:  Xun Ai; Jiajie Yan; Elena Carrillo; Wenmao Ding
Journal:  Rev Physiol Biochem Pharmacol       Date:  2016       Impact factor: 5.545

Review 3.  Omega-3 Polyunsaturated Fatty Acid Supplementation: Mechanism and Current Evidence in Atrial Fibrillation.

Authors:  Savina Nodari; Marco Triggiani; Umberto Campia; Livio Dei Cas
Journal:  J Atr Fibrillation       Date:  2012-12-16

Review 4.  Connexin Remodeling Contributes to Atrial Fibrillation.

Authors:  Michelle M Jennings; J Kevin Donahue
Journal:  J Atr Fibrillation       Date:  2013-08-31

Review 5.  Atrial Remodeling And Atrial Fibrillation: Mechanistic Interactions And Clinical Implications.

Authors:  Bandar Al Ghamdi; Walid Hassan
Journal:  J Atr Fibrillation       Date:  2009-06-01

6.  Connexin gene transfer preserves conduction velocity and prevents atrial fibrillation.

Authors:  Tomonori Igarashi; J Emanuel Finet; Ayano Takeuchi; Yoshihisa Fujino; Maria Strom; Ian D Greener; David S Rosenbaum; J Kevin Donahue
Journal:  Circulation       Date:  2011-12-08       Impact factor: 29.690

Review 7.  Novel molecular targets for atrial fibrillation therapy.

Authors:  Dobromir Dobrev; Leif Carlsson; Stanley Nattel
Journal:  Nat Rev Drug Discov       Date:  2012-03-30       Impact factor: 84.694

Review 8.  Connexins in Cardiovascular and Neurovascular Health and Disease: Pharmacological Implications.

Authors:  Luc Leybaert; Paul D Lampe; Stefan Dhein; Brenda R Kwak; Peter Ferdinandy; Eric C Beyer; Dale W Laird; Christian C Naus; Colin R Green; Rainer Schulz
Journal:  Pharmacol Rev       Date:  2017-10       Impact factor: 25.468

9.  A new role for extracellular Ca2+ in gap-junction remodeling: studies in humans and rats.

Authors:  S Dhein; N Duerrschmidt; A Scholl; A Boldt; J S Schulte; B Pfannmüller; D Rojas-Gomez; A Scheffler; J-A Haefliger; N Doll; F-W Mohr
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-02-16       Impact factor: 3.000

10.  New antiarrhythmic drugs for atrial fibrillation: focus on dronedarone and vernakalant.

Authors:  A John Camm; Irina Savelieva
Journal:  J Interv Card Electrophysiol       Date:  2008-06-04       Impact factor: 1.900

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.